Literature DB >> 3845121

Antimicrobial resistance in coagulase-negative staphylococci.

J M Hamilton-Miller, A Iliffe.   

Abstract

Patterns of resistance to antimicrobial agents were studied in 193 strains of coagulase-negative staphylococci isolated from hospital patients. Strains isolated from patients with malignant disease were significantly more often resistant to sulphonamide, trimethoprim, gentamicin and methicillin than were strains from other sources. Susceptibility to various beta-lactam antibiotics and aminoglycosides was investigated in members of the two most frequent species: Staphylococcus epidermidis and S. haemolyticus. S. haemolyticus strains were not only more often resistant to methicillin than S. epidermidis strains (respectively 81% and 17%) but they were more highly resistant (mean MICs respectively 85 and 19 mg/L). Methicillin-resistant S. haemolyticus strains were highly resistant to nine other beta-lactam antibiotics, whereas methicillin-resistant S. epidermidis strains showed both lower levels and a narrower spectrum of cross-resistance. Resistance to methicillin in members of both species was "heterogeneous", i.e., only a minority of cells in a culture showed significant resistance. Almost all gentamicin-resistant strains were sensitive to netilmicin and amikacin; rifampicin, vancomycin and teicoplanin were also highly active in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3845121     DOI: 10.1099/00222615-19-2-217

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

1.  Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide.

Authors:  P R Hunter; R C George; J W Griffiths
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 2.  The emergence of antibiotic resistance: myths and facts in clinical practice.

Authors:  J M Hamilton-Miller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 3.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Prevalence of peritonitis-associated coagulase-negative staphylococci on the skin of continuous ambulatory peritoneal dialysis patients.

Authors:  M A Beard-Pegler; C L Gabelish; E Stubbs; C Harbour; J Robson; M Falk; R Benn; A Vickery
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

5.  Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

6.  Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens.

Authors:  M A Deighton; J C Franklin; W J Spicer; B Balkau
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

7.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 8.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

9.  Detection of methicillin-resistant Staphylococcus epidermidis.

Authors:  G L Woods; G S Hall; I Rutherford; K J Pratt; C C Knapp
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

10.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.